Viewing Study NCT00280332


Ignite Creation Date: 2025-12-24 @ 9:32 PM
Ignite Modification Date: 2025-12-25 @ 7:16 PM
Study NCT ID: NCT00280332
Status: COMPLETED
Last Update Posted: 2008-05-12
First Post: 2006-01-20
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Follow-up Colonoscopy Examination in Patients Who Had Previously Undergone Screening Colonoscopy
Sponsor: Chinese University of Hong Kong
Organization:

Study Overview

Official Title: A Follow-up Colonoscopy Examination in Patients Who Had Previously Undergone Screening Colonoscopy
Status: COMPLETED
Status Verified Date: 2008-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: * To determine the prevalence of colonic neoplasm in patients who had previously undergone screening colonoscopy
* To determine the optimal time interval for re-screening in average risk individuals
* To determine potential baseline characteristics that predicts adenoma recurrence
Detailed Description: Colorectal cancer (CRC) is the second commonest cancer in Hong Kong, and tends to be increasing. Screening for colorectal cancer can reduce the cancer incidence and mortality by detecting early lesions. However, the best interval for a follow up colonoscopy, particularly for those with normal baseline colonoscopy, remains largely unknown.

This study aim to determine the prevalence of colonic neoplasm in average-risk patients who had previously undergone screening colonoscopy and the optimal time interval for re-screening.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: